(Q33342531)

English

Pegylated liposomal doxorubicin in combination chemotherapy in the treatment of previously untreated aggressive diffuse large-B-cell lymphoma

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Pegylated liposomal doxorubicin in combination chemotherapy in the treatment of previously untreated aggressive diffuse large-B-cell lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Natividad Neri

2

0 references

author name string

Agustin Avilés

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Claudia Castañeda

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Alejandra Talavera

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Judith Huerta-Guzmán

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Martha González

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

55-58

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025891

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous stem cell transplantation for malignancy: a systematic review of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025891

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025891

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative study of the antitumor activity of free doxorubicin and polyethylene glycol-coated liposomal doxorubicin in a mouse lymphoma model

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025891

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025891

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025891

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical impact of chemotherapy dose escalation in patients with hematologic malignancies and solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025891

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025891

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pegylated doxorubicin for primary cutaneous T-cell lymphoma: a report on ten patients with follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025891

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025891

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025891

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose escalation of epirubicin in the CEOP-BLEO regimen: a controlled clinical trial comparing standard doses for the treatment of diffuse large cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025891

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant radiotherapy to sites of previous bulky disease in patients stage IV diffuse large cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025891

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1385/MO:19:1:55

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33342531&oldid=2195263320"